Related Experiment Video
Updated: Jul 19, 2026

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
Alveolar soft-part sarcoma: a review and update.
1Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA. folpe.andrew@mayo.edu
Journal of Clinical Pathology
|October 31, 2006
Summary
Alveolar soft-part sarcoma (ASPS) is a rare cancer in young patients with a poor prognosis due to late metastases. Recent research has significantly advanced the understanding of ASPS genetic causes and pathogenesis.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Alveolar soft-part sarcoma (ASPS) is a rare and distinct tumor type.
- It predominantly affects young individuals.
- ASPS is known for its indolent clinical behavior but carries a poor prognosis, often involving late metastatic spread.
Purpose of the Study:
- To provide a comprehensive review of Alveolar soft-part sarcoma (ASPS).
- To consolidate current knowledge on the historical, histopathological, ultrastructural, immunohistochemical, and genetic aspects of ASPS.
- To highlight recent advancements in understanding ASPS pathogenesis.
Main Methods:
- Literature review and synthesis of existing data.
- Analysis of historical, histopathological, ultrastructural, and immunohistochemical features.
- Review of recent genetic findings related to ASPS pathogenesis.
Main Results:
- ASPS is characterized by specific histopathological and ultrastructural findings.
- Immunohistochemistry aids in its diagnosis.
- Significant progress has been made in identifying the genetic underpinnings of ASPS.
Conclusions:
- ASPS remains a challenging diagnosis with a poor prognosis despite its rarity.
- Understanding the genetic landscape is crucial for future therapeutic strategies.
- This review synthesizes key aspects, providing a foundation for further research in ASPS.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

